Diabetics receiving self-injection training and counseling by pharmacists were 24 percent more likely to be medication adherent, according to a new study from Walgreens.
The study evaluated Walgreens’ first nationwide training program for diabetic patients prescribed a self-injectable diabetes medication. For the study, Walgreens pharmacists trained over 4,500 patients starting the medication for the first time on appropriate injection technique, side effect management and the importance of adherence to therapy. Pharmacists also provided a follow-up assessment at the patients’ next refill.
Initial results showed that patients who received two counseling sessions with a pharmacist were 24 percent more adherent after 90 days and had an additional eight days of therapy compared to a usual care control group.
Studies show that more than 25.8 million children and adults have been diagnosed with diabetes in the United States, costing the United States’ healthcare system an estimated $174 billion per year. While the total cost of medication non-adherence for diabetes patients is unknown, a recent study outlining a scenario where goals of diabetes therapy are successfully achieved shows that medical cost savings could improve by 20 percent, or an estimated $325 billion, in 30 years.
IMPORTANT NOTICE: This information is designed to provide accurate and authoritative information on the business of healthcare. It is distributed with the understanding that Healthcare Intelligence Network is not engaged in rendering legal advice. If legal advice is required, the services of a competent professional should be retained.